| |
|
|
| Name: |
Lynx1 Capital Management LP |
| City: |
HUMACAO |
| State: |
PR |
| Zip: |
00791 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
20 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
GHRS |
Gh Research Ord Shs |
1 |
- |
$0.00 |
$71,077,000 |
6,443,940 |
25.45% |
37,064,000 |
1,584,946 |
13.191 |
N/A |
|
|
MRUS |
Merus Nv |
2 |
- |
$53.82 |
$66,033,000 |
1,568,841 |
23.65% |
-441,000 |
-12,000 |
2.19 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
3 |
New |
$51.05 |
$35,449,000 |
733,014 |
12.69% |
35,449,000 |
733,014 |
1.146 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
4 |
- |
$11.48 |
$35,191,000 |
5,291,929 |
12.6% |
-22,024,000 |
104,738 |
8.447 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
5 |
- |
$0.00 |
$24,343,000 |
3,215,722 |
8.72% |
9,023,000 |
1,957,927 |
0.739 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
6 |
- |
$0.00 |
$16,143,000 |
11,057,009 |
5.78% |
-7,020,000 |
182,286 |
5.288 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
7 |
- |
$0.00 |
$11,357,000 |
7,098,133 |
4.07% |
-13,313,000 |
245,389 |
10.237 |
N/A |
|
|
TCRX |
Tscan Therapeutics, Inc. |
8 |
- |
$0.00 |
$7,393,000 |
5,357,347 |
2.65% |
-8,893,000 |
0 |
12.302 |
N/A |
|
|
DTIL |
Precision Biosciences Inc |
9 |
- |
$4.34 |
$3,654,000 |
766,051 |
1.31% |
735,000 |
0 |
0.691 |
N/A |
|
|
IBIO |
Ibio Ord Shs |
10 |
- |
$0.20 |
$3,466,000 |
862,279 |
1.24% |
1,353,000 |
0 |
0.958 |
Drug Manufacturers - ... |
|
|
PASG |
Passage Bio, Inc. |
11 |
- |
$0.46 |
$3,269,000 |
9,256,953 |
1.17% |
-1,981,000 |
0 |
20.332 |
N/A |
|
|
UPB |
Upstream Bio, Inc. |
12 |
- |
$11.20 |
$1,342,000 |
219,247 |
0.48% |
-2,604,000 |
-20,795 |
0.414 |
N/A |
|
|
NEUP |
Neuphoria Therapeutics Inc |
13 |
- |
$7.13 |
$264,000 |
45,806 |
0.09% |
107,000 |
0 |
2.603 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
14 |
New |
$0.00 |
$255,000 |
65,954 |
0.09% |
255,000 |
65,954 |
0.119 |
N/A |
|
|
RPTX |
Repare Therapeutics Inc. |
16 |
Closed |
$0.00 |
$0 |
0 |
0% |
-104,000 |
-79,176 |
0 |
N/A |
|
|
CRBU |
Caribou Biosciences, Inc. |
15 |
Closed |
$1.37 |
$0 |
0 |
0% |
-1,082,000 |
-680,189 |
0 |
N/A |
|
|
VOR |
Vor Biopharma Inc. |
20 |
Closed |
$0.00 |
$0 |
0 |
0% |
-707,000 |
-637,218 |
0 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
19 |
Closed |
$0.00 |
$0 |
0 |
0% |
-291,000 |
-17,400 |
0 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
18 |
Closed |
$0.00 |
$0 |
0 |
0% |
-8,612,000 |
-544,001 |
0 |
N/A |
|
|
ALLK |
Allakos Inc. |
17 |
Closed |
$0.33 |
$0 |
0 |
0% |
-4,390,000 |
-3,628,144 |
0 |
N/A |
|
